Interested in Language Strategy? Wondering what your audience is thinking? Connect with us. We'd love to hear from you.| maslansky+partners
There are moments in American politics when the ground shifts beneath our feet; when something that seemed fringe, even laughable, suddenly becomes the center of gravity. Today, that something is the MAHA movement: "Make America Healthy Again." According to Lee Carter in this opinion piece for FoxNews.com, dismissing MAHA is not just shortsighted, it’s dangerous. The post Lee Carter on the MAHA Initiative: Opinion piece on Foxnews.com appeared first on maslansky+partners.| maslansky+partners
Every day, in boardrooms, break rooms, and across the internet, people are shaping their own version of your company’s story—whether it’s accurate or not. Here’s the hard truth: If you don’t own your narrative, someone else will. And when that happens, you can lose control—not just of your story, but of your brand, your reputation, and your future. On this episode of HearSay, we dive into a critical question every business leader should be asking: Do you have a corporate narrative...| maslansky+partners
News that RFK Jr. will push to change the childhood vaccine schedule is putting intense new scrutiny on recommendations. When pharma responds with “trust the science” or appeals to authority of the CDC’s past recommendations, these messages often fall flat—or worse, appear dismissive. The post Why Pharma Must Rethink How It Explains the Vaccine Schedule—Not Just Defend It appeared first on maslansky+partners.| maslansky+partners
Does your company have a corporate narrative? Is it the right one? Ben Feller says it may be time to see if your narrative is doing its job--and offers three ways to help find the right one.| maslansky+partners
By| maslansky+partners
By| maslansky+partners
The Make America Healthy Again (MAHA) Commission has dropped its roadmap, and while the headlines sound like the usual policy fare (“modernize vaccines,” “expand injury research,” “re-evaluate childhood schedules”), what’s really happening is a communications earthquake. Ignore it, and you do so at your own peril. The post Vaccines, DTC, MAHA, and the Battle for Trust: Why Pharma Can’t Afford to Sit This One Out appeared first on maslansky+partners.| maslansky+partners
What's in a name? Everything, if you consider the Trump administration's decision to rechristen the Department of Defense to the Department of War. Lee Carter chimes in on the debate in this provocative thought piece. The post Lee Carter on “The Dept of War”: Opinion piece on Foxnews.com appeared first on maslansky+partners.| maslansky+partners
HR leader Nile Hull shares five language tactics for interviews, to help candidates use language thoughtfully and authentically.| maslansky+partners
Nile Hull is Senior Vice President of Talent for maslansky + partners. Learn more about Nile.| maslansky+partners
Explore careers at maslansky+partners, where we bring unique expertise as strategists, researchers, and communicators.| maslansky+partners
HR leader Nile Hull shares five language tactics for interviews, to help candidates use language thoughtfully and authentically.| maslansky+partners
By| maslansky+partners
We’re the creator and leader of Language Strategy®, the singular discipline of finding exactly the right words to make audiences listen, care and act.| maslansky+partners
The Fairness Factor:| maslansky+partners
By| maslansky+partners
In our work, we often hear “insights,” “learnings,” and “findings” used interchangeably. But are they really the same? And does it matter which one you use?| maslansky+partners
If you wanted a case study in why so many Americans believe the system is rigged, you couldn’t script it better than what’s happening in Texas right now, according to Lee Carter in this opinion piece for FoxNews.com. The post Lee Carter: Opinion piece on Foxnews.com appeared first on maslansky+partners.| maslansky+partners
Americans see Republicans and Democrats fighting over everything but what matters most to them. Lee Carter shares her views on the latest Congressional polls and what Americans are really focused on, in her latest appearance on CNN. The post Lee Carter on CNN: Latest Congressional polls – what do Americans really care about? appeared first on maslansky+partners.| maslansky+partners
The controversy around American Eagle’s "good genes" jeans ad with Sydney Sweeney is not about denim or DNA. Lee Carter explores why the left and the right are so outraged.| maslansky+partners
Lee Carter says that the path is now clear—if the Democratic party is willing to learn from its own, and from its greatest rival.| maslansky+partners
maslansky+partners helps organizations communicate better through Language Strategy, finding the right words to make audiences listen, care, and act.| maslansky+partners
By| maslansky+partners
By| maslansky+partners
Chris Foster, CEO of OPRG, joins HearSay to share highlights from new Maslansky + Partners research that examines the state of the world and business today.| maslansky+partners
Is there room for a third political party in America? Michael Maslansky shared his views recently on Fox News.| maslansky+partners
Michael Maslansky shares how Musk’s idea for an “America Party” is a case study in how NOT to build trust through language.| maslansky+partners
Lee Carter shares four key steps pharma companies can take to engage more productively with the MAHA movement.| maslansky+partners
Lee Carter reflects on how in moments of crisis—like the recent strikes on Iran nuclear sites—language is not just a reflection of reality, but a force that shapes it.| maslansky+partners
When it comes to corporate storytelling, companies can use the Goldilocks Principle to find the communication approach that's "just right."| maslansky+partners
Lee Carter joined CNN’s Kate Bolduan and Van Jones for a sharp analysis on new polling of how Americans view the US strike against Iran.| maslansky+partners
Partner Ben Feller shares how a simple moment with his son sparks a powerful call to reshape the way we talk about modern fatherhood.| maslansky+partners
Lee Carter joins host Jason Chaffetz on the Jason in the House podcast for a conversation on “The Importance of Looking Beyond the Data.”| maslansky+partners
Michael Maslansky offers some sound advice for how companies can communicate effectively about tariffs while mitigating the risk.| maslansky+partners
In this episode of Hearsay, we unpack why communicating effectively—especially in industries like pharma—is harder than ever.| maslansky+partners
In responding to the executive order on drug pricing, pharma companies have a chance to redefine their narrative.| maslansky+partners
With President Trump and RFK Jr’s focus on pharma and health, companies need to engage; they need to be telling the right pharma story.| maslansky+partners
People are angry. From DEI to tariffs and rising prices, companies need to understand how to respond & communicate in this new "age of rage."| maslansky+partners
Tune in to this episode of HearSay to hear firsthand how businesses can continue to champion DEI amidst a rapidly shifting landscape.| maslansky+partners
Here are five corporate communication strategies that won't work in this evolving environment, and a guide on how to communicate successfully.| maslansky+partners
Five steps companies can take that will allow them to continue to work towards their DEI goals while mitigating the risk.| maslansky+partners
Democrats had a big challenge for this year's DNC: reintroduce Kamala Harris to the American public and redefine the party’s vision for the future. It was an opportunity to reframe and reshape their entire campaign narrative. We analyzed their strategic shifts in language and messaging—and how it transformed the voice of their campaign.| maslansky+partners
Partner Keith Yazmir shares insights on why selling innovation in technology is hard. This piece shares some provocative thoughts and insightful tips for tech marketers, to successfully drive adoption of innovative tech.| maslansky+partners
In this episode, we dissect the challenges of selling innovation whether you are selling enterprise technology, a new investment product, or plant-based meat.| maslansky+partners